Peptide Reference Database
Clinical reference database covering mechanisms, dosing protocols, combinations, and contraindications.
44Peptides
9Categories
4Evidence Tiers
Want a personalised protocol?
Our AI generator builds a protocol tailored to your profile and goals.
Evidence tier:Tier 1 β Strong RCT/clinical evidenceTier 2 β Good human studiesTier 3 β Animal + early humanTier 4 β Preclinical only
2 peptides
Metabolic
T1Semaglutide
Ozempic Β· Wegovy
Long-acting GLP-1 receptor agonist with FDA approval for T2 diabetes and obesity.
metabolicGLP-1obesitydiabetes
SC injection / OralView profile β
Metabolic
T1Tirzepatide
Mounjaro Β· Zepbound
Dual GIP/GLP-1 receptor agonist (first in class) with superior weight loss outcomes (~22% body weight) compared to semaglutide in head-to-head trials.
metabolicGLP-1GIPobesity
SC injectionView profile β
MaraPeptide Β· NAD+ revolution
Improve your energy, appearance and recovery the natural way in just a few weeks
Complete NAD+ protocol for free!